Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2003
05/22/2003US20030096761 Angiotensin converting enzyme (ACE) and/or neutral endopeptidase (NEP); organic acids and salts thereof, sodium lauryl sulfate and palmitoyl carnitine enhancers used in treating cardiovascular disorders
05/22/2003US20030096734 Sodium hyaluronate microspheres
05/22/2003US20030096354 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders
05/22/2003US20030096266 Hydrophobic biopolymer for use in the treatment of infections, blood, inflammatory and muscular disorders
05/22/2003US20030096097 Process for antibiotic coating of elements with interconnecting microcavities, elements thus coated as well as their usage
05/22/2003US20030096025 Oolong tea extract
05/22/2003US20030096024 Controlled release saw palmetto extract; optionally antispasmodic agent to reduce smooth muscle contractions
05/22/2003US20030096014 Coprecipitate of itraconazole and a water-soluble nonpolymeric compound such as a nonvolatile acid.
05/22/2003US20030096013 Seeding a drug in a first phase causing a phase change in the drug to a second phase of a desired polymorphic form
05/22/2003US20030096012 Film-forming powder, compositions containing it, methods for their preparation and their uses
05/22/2003US20030096011 Wet milling suspension of labile agent dispersed in biocompatible polymer and solvent; drying to form solid polymer/labile agent matrix
05/22/2003US20030096010 Random copolymer of an N-alkyl- or N,N-dialkyl(meth)acrylamide and a hydrophilic comonomer; may be a graft polymer; drug delivery
05/22/2003US20030096009 Methods and compositions for the treatment of benign prostatic hypertrophy
05/22/2003US20030096008 Tetracycline - Doxycycline antibiotic composition
05/22/2003US20030096007 Amoxicillin-dicloxacillin antibiotic composition
05/22/2003US20030096006 Three dosage forms with different release profiles
05/22/2003US20030096005 Pharmaceutical excipient having improved compressibility
05/22/2003US20030096004 (S,S'),(S,R')-amphetaminil, compositions and uses thereof
05/22/2003US20030096003 Excipients containing low residual solvent and method for producing the same
05/22/2003US20030096002 Delivery system for biological component
05/22/2003US20030096001 Encapsulation products and method of controlled release of fluoxetine or mesalamine
05/22/2003US20030096000 Encapsulation of nanosuspensions in liposomes and microspheres
05/22/2003US20030095999 The fusogenic protein is associated with a phospholipid membrane, such as a liposome.
05/22/2003US20030095998 Fiber-based nano drug delivery systems (NDDS)
05/22/2003US20030095997 Preferably collagen; capable of promoting formation of granulation tissue, angiogenesis, vascularization and epithelization; useful in surgical suturing.
05/22/2003US20030095995 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
05/22/2003US20030095987 Recombinant parainfluenza virus expression system and vaccines
05/22/2003US20030095974 Containing a metabolisable oil; vaccine adjuvants; saponin may be QuilA or derivative thereof, such as QS21; oil may be squalene
05/22/2003US20030095928 Nanoparticulate insulin
05/22/2003US20030095927 Provides biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect.
05/22/2003US20030095926 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
05/22/2003US20030095925 For rapid absorption through the oral mucosa, resulting in fast onset of effect.
05/22/2003US20030094715 Method for preparing microsphere
05/22/2003US20030094104 Process tolerant low amylose tapioca distarch adipates
05/22/2003CA2784450A1 Polypeptides of pseudomonas aeruginosa
05/22/2003CA2472019A1 Production of cell suspensions
05/22/2003CA2467239A1 Catheter injectable depot compositions and uses thereof
05/22/2003CA2467167A1 High-concentration lidocaine compositions and methods for their preparation
05/22/2003CA2467060A1 Lipid carrier compositions and methods for improved drug retention
05/22/2003CA2467056A1 Carotenoid composition and method for protecting skin
05/22/2003CA2466998A1 Biocompatible polymer blends and uses thereof
05/22/2003CA2466641A1 Lyophilized monoclonal antibody compositions
05/22/2003CA2466632A1 Injectable depot compositions and uses thereof
05/22/2003CA2466504A1 Oral dosage form of a sulfonamide prodrug
05/22/2003CA2466422A1 Methods and compositions for use of (s)-bisoprolol
05/22/2003CA2463481A1 Three-dimensional suspension printing of dosage forms
05/22/2003CA2461481A1 Ptp1b inhibitors and ligands
05/21/2003EP1312371A1 Animal papilla disinfectants and method of improving microbial environment
05/21/2003EP1312368A1 Composition comprising mesalazine for the treatment of inflammatory bowel diseases
05/21/2003EP1312366A1 Aqueous pharmaceutical compositions
05/21/2003EP1312360A1 Analgesic/antiinflammatory patches for topical use
05/21/2003EP1312358A1 Solid pharmaceutical compositions for oral administration comprising itraconazole
05/21/2003EP1312357A2 Pharmaceutical formulations for dry powder inhalers
05/21/2003EP1312356A1 Aqueous suspension preparations
05/21/2003EP1312355A1 Water-soluble non-effervescent pharmaceutical compositions comprising non-steroidal anti-inflammatory drugs
05/21/2003EP1312025A2 System and method for rapidly customizing a design and remotely manufacturing biomedical devices using a computer system
05/21/2003EP1311861A2 Test unit and method for the production of stable formulations
05/21/2003EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
05/21/2003EP1311522A1 New immunoeffector compounds
05/21/2003EP1311491A1 Use of triazinetrione sulfones for combating coccidiosis
05/21/2003EP1311474A1 Sulfonamide derivatives
05/21/2003EP1311296A2 Solution of an oxazolidinone antibiotic drug
05/21/2003EP1311295A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
05/21/2003EP1311294A2 Formulations of mometasone and a bronchodilator for pulmonary administration
05/21/2003EP1311285A2 Liquid pharmaceutical composition containing an erythropoietin derivative
05/21/2003EP1311275A1 A synthetic bulk laxative
05/21/2003EP1311273A2 Combination of a purine and an nsaid for treating sexual dysfunction
05/21/2003EP1311271A1 Use of triazinetrione sulfoxides for controlling coccidioses
05/21/2003EP1311261A1 Medicaments for chemotherapeutic treatment of disease
05/21/2003EP1311259A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
05/21/2003EP1311249A1 Transdermal therapeutic system
05/21/2003EP1311248A1 Transdermal therapeutic system for treating restless-legs-syndrome
05/21/2003EP1311247A1 Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
05/21/2003EP1311246A2 Method of preparing stable bleached shellac
05/21/2003EP1311245A1 Hybrid neuroprosthesis for the treatment of brain disorders
05/21/2003EP1311244A2 Steroid hormones as transfer agents
05/21/2003EP1311243A2 Process for the production and use of powdered mannitol and mannitol-containing compositions
05/21/2003EP1311242A1 Active agent delivery systems and methods for protecting and administering active agents
05/21/2003EP1311241A2 Use of a porous carrier
05/21/2003EP1311240A1 Method for preparation of chewing gum with customer acceptable taste
05/21/2003EP1311239A1 Oral delivery of peptide
05/21/2003EP1311233A1 Substances for inducing and intensifying the tanning mechanisms of the skin and cosmetic or dermatological preparations which contain said substances
05/21/2003EP1311213A1 Vaginal delivery of bisphosphonates
05/21/2003EP1244444A4 Process for formulation of carbapenem antibiotic compositions
05/21/2003EP1200066B1 Aqueous nasal formulation
05/21/2003EP1194452B1 Process for making cellulose ethers having reduced yellowing and discoloration
05/21/2003EP1156783A4 Encapsulation of bioactive complexes in liposomes
05/21/2003EP1144003A4 Methods and devices for delivery of agents to breast milk ducts
05/21/2003EP1041895A4 Animal feed pelleting process and animal feed pellets produced therefrom
05/21/2003EP1039802B1 Transdermal therapeutic device with capsaicin and capsaicin analogs
05/21/2003EP1017367B1 Methods for fabricating polymer-based controlled release preparations
05/21/2003EP0991616B1 METHOD FOR PRODUCING MEDICAMENTS CONTAINING HMG-CoA-REDUCTASE INHIBITORS
05/21/2003EP0981334B1 Swallow tablet comprising paracetamol
05/21/2003EP0966268B1 Cross-linked plant protein particles, in particular microparticles or nanoparticles, preparation method and cosmetic, pharmaceutical or food compositions containing same
05/21/2003EP0954290B1 Controlled-release pharmaceutical tablet containing a carrier based on cross-linked amylose and hydroxypropylmethylcellulose
05/21/2003EP0888111B1 Modified release multiple-units dosage composition
05/21/2003EP0886521B1 Topical bisphosphonates for prevention of bone resorption
05/21/2003EP0831703A4 Method of solubilizing and encapsulating itraconazole
05/21/2003EP0784974B1 preparation of xanthine derivatives in a solid dispersion
05/21/2003EP0769973B1 Device for intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
1 ... 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 ... 2991